Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

A comparison between the effects of flaxseed oil and fish oil supplementation on cardiovascular health in type 2 diabetic patients with coronary heart disease: A randomized, double-blinded, placebo-controlled trial.

Raygan F, Taghizadeh M, Mirhosseini N, Akbari E, Bahmani F, Memarzadeh MR, Sharifi N, Jafarnejad S, Banikazemi Z, Asemi Z.

Phytother Res. 2019 Jul;33(7):1943-1951. doi: 10.1002/ptr.6393. Epub 2019 Jun 13.

PMID:
31190359
2.

Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure.

Sarkkinen ES, Savolainen MJ, Taurio J, Marvola T, Bruheim I.

Lipids Health Dis. 2018 Dec 20;17(1):287. doi: 10.1186/s12944-018-0935-x.

3.

Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial.

Yang B, Shi L, Wang AM, Shi MQ, Li ZH, Zhao F, Guo XJ, Li D.

J Agric Food Chem. 2019 Jan 9;67(1):184-192. doi: 10.1021/acs.jafc.8b05463. Epub 2018 Dec 18.

PMID:
30511840
4.

Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE; VITAL Research Group.

N Engl J Med. 2019 Jan 3;380(1):23-32. doi: 10.1056/NEJMoa1811403. Epub 2018 Nov 10.

PMID:
30415637
5.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
6.

Effects of Long Chain Omega-3 Polyunsaturated Fatty Acids on Brain Function in Mildly Hypertensive Older Adults.

Howe PRC, Evans HM, Kuszewski JC, Wong RHX.

Nutrients. 2018 Oct 2;10(10). pii: E1413. doi: 10.3390/nu10101413. Erratum in: Nutrients. 2019 May 10;11(5):.

7.

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).

Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T.

Vasc Health Risk Manag. 2018 Sep 18;14:225-232. doi: 10.2147/VHRM.S171143. eCollection 2018.

8.

Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial.

Rantanen JM, Riahi S, Johansen MB, Schmidt EB, Christensen JH.

Nutrients. 2018 Sep 17;10(9). pii: E1313. doi: 10.3390/nu10091313.

9.

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

ASCEND Study Collaborative Group, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, Murphy K, Aung T, Haynes R, Cox J, Murawska A, Young A, Lay M, Chen F, Sammons E, Waters E, Adler A, Bodansky J, Farmer A, McPherson R, Neil A, Simpson D, Peto R, Baigent C, Collins R, Parish S, Armitage J.

N Engl J Med. 2018 Oct 18;379(16):1540-1550. doi: 10.1056/NEJMoa1804989. Epub 2018 Aug 26.

10.

Does administration of eicosapentaenoic acid increase soluble thrombomodulin level in statin-treated patients with stable coronary artery disease?

Tani S, Matsuo R, Hirayama A.

Heart Vessels. 2019 Feb;34(2):368-374. doi: 10.1007/s00380-018-1240-3. Epub 2018 Aug 24.

PMID:
30143885
11.

Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.

Jiang W, Whellan DJ, Adams KF, Babyak MA, Boyle SH, Wilson JL, Patel CB, Rogers JG, Harris WS, O'Connor CM.

JACC Heart Fail. 2018 Oct;6(10):833-843. doi: 10.1016/j.jchf.2018.03.011. Epub 2018 Aug 8.

12.

Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure.

Wurm R, Schrutka L, Hammer A, Moertl D, Berger R, Pavo N, Lang IM, Goliasch G, Huelsmann M, Distelmaier K.

Eur J Clin Invest. 2018 Sep;48(9):e12998. doi: 10.1111/eci.12998. Epub 2018 Aug 1.

13.

Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy.

See VHL, Mori TA, Prescott SL, Beilin LJ, Burrows S, Huang RC.

Pediatrics. 2018 Jul;142(1). pii: e20162623. doi: 10.1542/peds.2016-2623. Epub 2018 Jun 8.

14.

Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.

Song J, Hu M, Li C, Yang B, Ding Q, Wang C, Mao L.

Food Funct. 2018 Jun 20;9(6):3235-3243. doi: 10.1039/c7fo01566f.

PMID:
29781483
15.

The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

Alfaddagh A, Elajami TK, Saleh M, Elajami M, Bistrian BR, Welty FK.

J Clin Lipidol. 2018 Jul - Aug;12(4):937-947.e2. doi: 10.1016/j.jacl.2018.03.080. Epub 2018 Mar 14.

PMID:
29752179
16.

Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.

Romo-Hualde A, Huerta AE, González-Navarro CJ, Ramos-López O, Moreno-Aliaga MJ, Martínez JA.

Lipids Health Dis. 2018 May 9;17(1):103. doi: 10.1186/s12944-018-0750-4.

17.

Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study.

Tan A, Sullenbarger B, Prakash R, McDaniel JC.

Prostaglandins Leukot Essent Fatty Acids. 2018 May;132:23-29. doi: 10.1016/j.plefa.2018.03.010. Epub 2018 Apr 3.

18.

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

Bowman L, Mafham M, Stevens W, Haynes R, Aung T, Chen F, Buck G, Collins R, Armitage J; ASCEND Study Collaborative Group.

Am Heart J. 2018 Apr;198:135-144. doi: 10.1016/j.ahj.2017.12.006. Epub 2017 Dec 24.

19.

Effect of Eicosapentaenoic acid (EPA) supplementation on cardiovascular markers in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.

Golzari MH, Javanbakht MH, Ghaedi E, Mohammadi H, Djalali M.

Diabetes Metab Syndr. 2018 May;12(3):411-415. doi: 10.1016/j.dsx.2018.03.003. Epub 2018 Mar 16.

PMID:
29588138
20.

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.

Brinton EA, Ballantyne CM, Guyton JR, Philip S, Doyle RT Jr, Juliano RA, Mosca L.

J Womens Health (Larchmt). 2018 Sep;27(9):1170-1176. doi: 10.1089/jwh.2017.6757. Epub 2018 Mar 27.

Supplemental Content

Loading ...
Support Center